Jump to content

ICI-199,441: Difference between revisions

Page 1
Page 2
Content deleted Content added
Nmatavka (talk | contribs)
No edit summary
Fixed spacing between stub template and category templates.
 
(34 intermediate revisions by 25 users not shown)
Line 1: Line 1:
{{short description|Chemical compound}}
{{Drugbox
{{Drugbox
| Verifiedfields = changed
| IUPAC_name = 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-phenyl-2-pyrrolidin-1-ylethyl]acetamide
| image = ICI-199441_structure.png
| Watchedfields = changed
| width = 200
| verifiedrevid = 411032066
| IUPAC_name = 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-phenyl-2-pyrrolidin-1-ylethyl]acetamide
| CAS_number = 115199-84-3
| smiles = Clc1ccc(cc1Cl)CC(=O)N(C)C(c3ccccc3)CN2CCCC2
| image = ICI-199,441 Structure.svg

| ATC_prefix =
| ATC_suffix =
<!--Clinical data-->| tradename =
| PubChem = 3082718
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| IUPHAR_ligand =
| DrugBank =
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| C=21|H=24|Cl=2|N=2|O=1
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| molecular_weight = 391.333 g/mol
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| bioavailability =
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| protein_bound =
| metabolism =
| legal_status =
| routes_of_administration = <!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| elimination_half-life =
| excretion =
| excretion = <!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| CAS_number = 116508-24-8
| UNII_Ref = {{fdacite|correct|FDA}}
| pregnancy_category=
| UNII = Q5R50X7L6M
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| ATC_prefix =
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| ATC_suffix =
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| PubChem = 3082718
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| IUPHAR_ligand = 11691
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| routes_of_administration =
| DrugBank =
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 38576
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 2340095

<!--Chemical data-->| C = 21
| H = 24
| Cl = 2
| N = 2
| O = 1
| smiles = CN([C@H](CN1CCCC1)c2ccccc2)C(=O)Cc3ccc(c(c3)Cl)Cl
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C21H24Cl2N2O/c1-24(21(26)14-16-9-10-18(22)19(23)13-16)20(15-25-11-5-6-12-25)17-7-3-2-4-8-17/h2-4,7-10,13,20H,5-6,11-12,14-15H2,1H3/t20-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = AEJOEPSMZCEYJN-HXUWFJFHSA-N
}}
}}


'''ICI-199,441''' is a drug which acts as a potent and selective [[kappa opioid receptor|κ-opioid]] [[agonist]], and has [[analgesic]] effects.<ref name="pmid2850924">{{cite journal |author=Costello GF, Main BG, Barlow JJ, Carroll JA, Shaw JS |title=A novel series of potent and selective agonists at the opioid kappa-receptor |journal=European Journal of Pharmacology |volume=151 |issue=3 |pages=475–8 |year=1988 |month=July |pmid=2850924 |doi= |url=}}</ref><ref name="pmid16123756">{{cite journal |author=Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, Suzuki T |title=Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala |journal=Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |volume=31 |issue=4 |pages=739–50 |year=2006 |month=April |pmid=16123756 |doi=10.1038/sj.npp.1300858 |url=}}</ref>
'''ICI-199,441''' is a drug which acts as a potent and selective [[kappa opioid receptor|κ-opioid]] [[agonist]], and has [[analgesic]] effects.<ref name="pmid2850924">{{cite journal | vauthors = Costello GF, Main BG, Barlow JJ, Carroll JA, Shaw JS | title = A novel series of potent and selective agonists at the opioid kappa-receptor | journal = European Journal of Pharmacology | volume = 151 | issue = 3 | pages = 475–478 | date = July 1988 | pmid = 2850924 | doi = 10.1016/0014-2999(88)90546-8 }}</ref><ref name="pmid16123756">{{cite journal | vauthors = Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, Suzuki T | display-authors = 6 | title = Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala | journal = Neuropsychopharmacology | volume = 31 | issue = 4 | pages = 739–750 | date = April 2006 | pmid = 16123756 | doi = 10.1038/sj.npp.1300858 | doi-access = free }}</ref> It is a [[biased agonist]] of the KOR, and is one of relatively few KOR ligands that is [[G protein]]-biased rather than [[β-arrestin]]-biased.<ref>{{cite journal | vauthors = DiMattio KM, Ehlert FJ, Liu-Chen LY | title = Intrinsic relative activities of κ opioid agonists in activating Gα proteins and internalizing receptor: Differences between human and mouse receptors | journal = European Journal of Pharmacology | volume = 761 | pages = 235–244 | date = August 2015 | pmid = 26057692 | pmc = 4532598 | doi = 10.1016/j.ejphar.2015.05.054 }}</ref>


== See also ==
*[[U-47700]]
*[[U-50488]]
*[[U-69,593]]


== References ==
{{Reflist|2}}


{{Opioidergics}}



==References==
<references/>

[[Category:Synthetic opioids]]
[[Category:Organochlorides]]
[[Category:Acetamides]]
[[Category:Acetamides]]
[[Category:Pyrrolidines]]
[[Category:Biased ligands]]
[[Category:Kappa agonists]]
[[Category:Chloroarenes]]
[[Category:Kappa-opioid receptor agonists]]
[[Category:1-Pyrrolidinyl compounds]]
[[Category:Synthetic opioids]]